The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.
-
-
Procyrion Inc. secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Aortix System. Aortix is a circulatory support device for chronic heart failure...
-
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the...
-
Edwards Lifesciences Corp. announced strategic clinical and regulatory milestones for its Edwards Pascal transcatheter valve repair system at the EuroPCR annual course, May 20-23 in Paris, France...
News | Heart Failure | September 18, 2019
September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track...
The REDUCE LAP HF-II study will combine Corvia Medical's InterAtrial Shunt Device (IASD), pictured here, with physIQ's continuous monitoring platform to evaluate the device's efficacy in patients with heart failure. Image courtesy of Corvia Medical.
News | Heart Failure | September 12, 2019
September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a...
News | Heart Valve Technology | September 11, 2019
September 11, 2019 — Percutaneous reduction of...
Image courtesy of Amazon.com
News | Heart Failure | September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse,...
News | Heart Failure | September 09, 2019
September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF...
News | Heart Failure | September 09, 2019
September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart...
News | Heart Failure | September 04, 2019
September 4, 2019 – Novartis announced results from two new...
News | Stem Cell Therapies | August 22, 2019
August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion...
Image courtesy of the American Heart Association
News | Cardiac Diagnostics | August 19, 2019
August 19, 2019 — People suffering from insomnia may have an...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo...
News | Heart Failure | August 14, 2019
Ancora Heart Enrolls First Patient in European Multi-center Study of AccuCinch Heart Failure Therapy
August 14, 2019 — Ancora Heart Inc. announced the first patient was enrolled in the CorCinch EU study, a European...
Technology | Heart Failure | July 30, 2019
July 30, 2019 – Procyrion Inc. secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA...
